Pegasus Pharmaceuticals Group Inc.(“Pegasus”) is a group of Canadian headquartered biotech and healthcare companies that specializes in research & development, manufacturing and commercialization of health products. It is dedicated to be a world leader in providing quality health products and services.

With dedicated efforts of some world-class scientists, Pegasus has established three independent innovative technological platforms: sapogenin-based Selective Metabolite Compound Drug (SMCD) development platform, Oral Bioavailability Enhancement Technology (OBET) platform and a platform using high-throughput peptide array screening and proteomic informatics to discover novel therapeutic and diagnostic molecules in a variety of diseases. All these technologies have been filed for patent applications, some of which are granted in US, China, Japan and Singapore.

Based on its proprietary technology, Pegasus has successfully put on the market a line of natural ginseng products, the CARESENG® Series and has received rapid market recognition and remarkable sales growth since its product launch in 2001, especially in North America, China and Japan.

Pegasus is also focusing on discovery and development of drugs against cancer and HIV AIDS. Some research programs are entering regulatory and clinical stages.